Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan C Cheng

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
Biochemistry|April 28, 2007
Structure of the catalytic domain of human polo-like kinase 1Michael Kothe, Darcy Kohls, Simon Low, et al.
Bioorganic & Medicinal Chemistry Letters|December 18, 2007
N-(3-(phenylcarbamoyl)arylpyrimidine)-5-carboxamides as potent and selective inhibitors of Lck: structure, synthesis and SARHolly L Deak, John R Newcomb, Joseph J Nunes, et al.
Bioorganic & Medicinal Chemistry Letters|July 13, 2010
Enhanced selectivity profile of pyrazole-urea based DFG-out p38alpha inhibitorsHu Liu, Cyrille Kuhn, Frederic Feru, et al.
Journal of Medicinal Chemistry|August 30, 2012
Structure- and property-based design of aminooxazoline xanthenes as selective, orally efficacious, and CNS penetrable BACE inhibitors for the treatment of Alzheimer's diseaseHongbing Huang, Daniel S La, Alan C Cheng, et al.
Communications Biology|July 31, 2023
Structural insights into selective small molecule activation of PKG1αEssam Metwally, Victor Mak, Aileen Soriano, et al.
Journal of Medicinal Chemistry|November 4, 2014
Inhibitors of β-site amyloid precursor protein cleaving enzyme (BACE1): identification of (S)-7-(2-fluoropyridin-3-yl)-3-((3-methyloxetan-3-yl)ethynyl)-5'H-spiro[chromeno[2,3-b]pyridine-5,4'-oxazol]-2'-amine (AMG-8718)Thomas A Dineen, Kui Chen, Alan C Cheng, et al.
ACS Medicinal Chemistry Letters|March 18, 2026
<i>N</i>‑Alkyl and <i>N</i>‑Aryl Aminopyrazole Spirocarbamates: A Two-Pronged Lead Optimization Strategy to Identify Orally Bioavailable Plasma Kallikrein InhibitorsRohan R Merchant, Natalia Chernyak, Jovan A Lopez, et al.
Frontiers in Immunology|May 23, 2022
Hexamerization of Anti-SARS CoV IgG1 Antibodies Improves Neutralization CapacityKalyan Pande, Scott A Hollingsworth, Miranda Sam, et al.
Journal of Medicinal Chemistry|November 13, 2014
Lead optimization and modulation of hERG activity in a series of aminooxazoline xanthene β-site amyloid precursor protein cleaving enzyme (BACE1) inhibitorsOleg Epstein, Marian C Bryan, Alan C Cheng, et al.
Chemical Biology & Drug Design|October 22, 2009
The design, synthesis and potential utility of fluorescence probes that target DFG-out conformation of p38alpha for high throughput screening binding assayHaile Tecle, Frederic Feru, Hu Liu, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Biochemistry|April 28, 2007
Structure of the catalytic domain of human polo-like kinase 1Michael Kothe, Darcy Kohls, Simon Low, et al.
Bioorganic & Medicinal Chemistry Letters|December 18, 2007
N-(3-(phenylcarbamoyl)arylpyrimidine)-5-carboxamides as potent and selective inhibitors of Lck: structure, synthesis and SARHolly L Deak, John R Newcomb, Joseph J Nunes, et al.
Bioorganic & Medicinal Chemistry Letters|July 13, 2010
Enhanced selectivity profile of pyrazole-urea based DFG-out p38alpha inhibitorsHu Liu, Cyrille Kuhn, Frederic Feru, et al.
Journal of Medicinal Chemistry|August 30, 2012
Structure- and property-based design of aminooxazoline xanthenes as selective, orally efficacious, and CNS penetrable BACE inhibitors for the treatment of Alzheimer's diseaseHongbing Huang, Daniel S La, Alan C Cheng, et al.
Communications Biology|July 31, 2023
Structural insights into selective small molecule activation of PKG1αEssam Metwally, Victor Mak, Aileen Soriano, et al.
Journal of Medicinal Chemistry|November 4, 2014
Inhibitors of β-site amyloid precursor protein cleaving enzyme (BACE1): identification of (S)-7-(2-fluoropyridin-3-yl)-3-((3-methyloxetan-3-yl)ethynyl)-5'H-spiro[chromeno[2,3-b]pyridine-5,4'-oxazol]-2'-amine (AMG-8718)Thomas A Dineen, Kui Chen, Alan C Cheng, et al.
ACS Medicinal Chemistry Letters|March 18, 2026
<i>N</i>‑Alkyl and <i>N</i>‑Aryl Aminopyrazole Spirocarbamates: A Two-Pronged Lead Optimization Strategy to Identify Orally Bioavailable Plasma Kallikrein InhibitorsRohan R Merchant, Natalia Chernyak, Jovan A Lopez, et al.
Frontiers in Immunology|May 23, 2022
Hexamerization of Anti-SARS CoV IgG1 Antibodies Improves Neutralization CapacityKalyan Pande, Scott A Hollingsworth, Miranda Sam, et al.
Journal of Medicinal Chemistry|November 13, 2014
Lead optimization and modulation of hERG activity in a series of aminooxazoline xanthene β-site amyloid precursor protein cleaving enzyme (BACE1) inhibitorsOleg Epstein, Marian C Bryan, Alan C Cheng, et al.
Chemical Biology & Drug Design|October 22, 2009
The design, synthesis and potential utility of fluorescence probes that target DFG-out conformation of p38alpha for high throughput screening binding assayHaile Tecle, Frederic Feru, Hu Liu, et al.
Pageof 6